HMGCS2 and Hepatic fibrosis: Notably, exogenous administration of β-OHB, not AcAc, has been previously described to increase liver fibrosis in mice [88] and inflammatory injury in hepatocytes [89], which may explain the observed trend in the Ad-HMGCS2 mice.